Basic Treatment Planning

RT in Cervix Cancer

• Definitive/Primary

Bulky IB2/IIA – IVB (PAN only)  Pelvic EBRT (45-50Gy/25-28#) +/- weekly cisplatin  Intra-cavitary brachytherapy (21-28Gy/3-4#)

• Adjuvant 

High Risk - +ve margins/parametrium/LNs (RT+C)  Intermediate Risk – LVSI, stromal invasion, size (RT alone)  45-50.4Gy/25-28# +/- cisplatin

• Salvage – recurrence following surgery

• Palliative

Peters (2000) JCO Apr; 18(8): 1606-13. Rotman (2006) IJROBP May 1; 65(1): 169-76.